MedTrace Logo

NR600 System Retinal Prosthesis for Patients With Retinal Degenerative Diseases

NCT04295304 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2023-03-15

No results posted yet for this study

Summary

The study objective is to demonstrate safety of the NR 600 System, and to evaluate the performance of the device in restoring visual activity of daily living in subjects with retinal degenerative diseases and severe visual impairment

Conditions

Interventions

DEVICE

Retinal surgery with implantation of epi-retinal device

Retinal surgery and implantation of epi-retinal prosthesis

Sponsors & Collaborators

  • MedPass International

    collaborator INDUSTRY

  • Nano Retina

    lead INDUSTRY

Principal Investigators

  • Weinberger Dov, Prof. · Retinal surgeon

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-17
Primary Completion
2023-03-09
Completion
2023-03-12

Countries

  • Belgium
  • Israel
  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04295304 on ClinicalTrials.gov